Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

Drug budget and prescription control measures are implemented regionally in Germany, meaning that the uptake of pharmaceuticals, including biosimilars, can vary by region. We examine regional market dynamics of tumor necrosis factor alpha (TNFα) inhibitor originators and biosimilars in Germany and s...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Evelien Moorkens, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, Steven Simoens
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2020-10-01
Saila:Pharmaceuticals
Gaiak:
infliximab
etanercept
TNFα inhibitors
biologics
biosimilars
Germany
Sarrera elektronikoa:https://www.mdpi.com/1424-8247/13/10/324
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak